Correlation Between HCW Biologics and Phio Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Phio Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Phio Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Phio Pharmaceuticals Corp, you can compare the effects of market volatilities on HCW Biologics and Phio Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Phio Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Phio Pharmaceuticals.

Diversification Opportunities for HCW Biologics and Phio Pharmaceuticals

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between HCW and Phio is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Phio Pharmaceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phio Pharmaceuticals Corp and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Phio Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phio Pharmaceuticals Corp has no effect on the direction of HCW Biologics i.e., HCW Biologics and Phio Pharmaceuticals go up and down completely randomly.

Pair Corralation between HCW Biologics and Phio Pharmaceuticals

Given the investment horizon of 90 days HCW Biologics is expected to generate 2.0 times more return on investment than Phio Pharmaceuticals. However, HCW Biologics is 2.0 times more volatile than Phio Pharmaceuticals Corp. It trades about 0.02 of its potential returns per unit of risk. Phio Pharmaceuticals Corp is currently generating about -0.03 per unit of risk. If you would invest  205.00  in HCW Biologics on August 30, 2024 and sell it today you would lose (154.79) from holding HCW Biologics or give up 75.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HCW Biologics  vs.  Phio Pharmaceuticals Corp

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Phio Pharmaceuticals Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile forward indicators, Phio Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.

HCW Biologics and Phio Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and Phio Pharmaceuticals

The main advantage of trading using opposite HCW Biologics and Phio Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Phio Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phio Pharmaceuticals will offset losses from the drop in Phio Pharmaceuticals' long position.
The idea behind HCW Biologics and Phio Pharmaceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years